News Focus
News Focus
icon url

DewDiligence

03/09/15 4:16 PM

#188383 RE: DewDiligence #187097

PTLA selling $115M* of stock at unspecified price:

http://finance.yahoo.com/news/portola-pharmaceuticals-announces-proposed-offering-201248535.html

*Assuming exercise of underwriter’s option.
icon url

DewDiligence

08/04/15 5:05 PM

#194071 RE: DewDiligence #187097

PTLA upsized the phase-3 trial of Betrixaban from 6850 to 7500 patients to maintain the desired statistical power. (Source: 2Q15 CC.)